Why the study?
Does in vivo DT-CMR characterize myocardial microstructural dynamics in patients with DCM and HCM?
Does in vivo DT-CMR characterize myocardial microstructural dynamics in patients with DCM and HCM?
In vivo DT-CMR provides novel noninvasive insights into contractile dysfunction by characterizing abnormal sheetlet function and conformation in DCM and HCM.
Answers are grounded in this paper and cite their sources.
DT-CMR may aid microstructural phenotyping of contractile dysfunction in DCM and HCM; hypothesis-generating and leaves open clinical utility.
Myocardial microstructure dynamics can be characterized by in vivo DT-CMR. Sheetlet function was abnormal in DCM with altered systolic conformation and reduced mobility, contrasting with HCM, which showed reduced mobility with altered diastolic conformation. These novel insights significantly improve understanding of contractile dysfunction at a level of noninvasive interrogation not previously available in humans.
No takes yet. Share an insight, caveat, or question.
Nielles‐Vallespin et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: